Craig Beasley Email

Chief Technology Officer . BlueRock Therapeutics

Current Roles

Employees:
553
Revenue:
$85.7M
About
BlueRock Therapeutics is a next-generation regenerative medicine company focused on breakthrough stem cell technology treatments of cardiovascular and neurodegenerative diseases. BlueRock Therapeutics has launched with the backing of a combined $225 million investment by Bayer and biotechnology investment firm Versant Ventures. BlueRock’s initial programs will focus on induced pluripotent stem cell (iPSC)-derived therapeutics to expand their technology pipeline.
BlueRock Therapeutics Address
238 Main Street
Cambridge, MA
United States

Past Companies

BlueRock TherapeuticsChief Technology Officer
Bristol Myers SquibbVP Supply Chain, Cell Therapy
Juno Therapeutics, Inc.VP Cell Therapy Supply Chain

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.